Pirfenidone

Details

Files

Generic Name:

Pirfenidone

Project Status:

Complete

Therapeutic Area:

Idiopathic pulmonary fibrosis

Manufacturer:

Hoffmann-La Roche Ltd.

Call for patient/clinician input open:

July 31, 2014

Brand Name:

Esbriet

Project Line:

Reimbursement Review

Project Number:

SR0393-000

Call for patient/clinician input closed:

September 22, 2014

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Resubmission

Indications:

Pulmonary fibrosis (idiopathic, mild to moderate)

Recommendation Type:

List with criteria/condition

Final Recommendation:

April 15, 2015

Files

Submission Status Report View PDF

Recommendations and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Last Updated : August 29, 2014